School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas, USA
School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas, USA.
BMJ Open. 2024 Nov 4;14(11):e084115. doi: 10.1136/bmjopen-2024-084115.
As the US continues to battle the opioid epidemic, recovery residences remain valuable services for people in recovery. While there is a growing body of literature describing positive outcomes experienced by people who live in recovery residences, little is known about the experience of people who live in these residences while taking medications for an opioid use disorder (MOUD) as part of their recovery. Thus, this study has three aims: (1) expand the availability of recovery residences that meet the National Alliance for Recovery Residences standards in Texas and serve individuals taking medications for an opioid use disorder as part of their recovery; (2) evaluate recovery residences for people taking MOUD as part of their recovery; and (3) compare the cost-effectiveness of recovery residences to treatment-as-usual.
In collaboration with community partners, we opened 15 recovery residences in the State of Texas to house people taking MOUD as part of their recovery. We are collecting quantitative and qualitative data to evaluate outcomes at the intrapersonal, interpersonal, organisational and community levels. At the intrapersonal level, we are assessing changes in behavioural and psychosocial constructs using a longitudinal survey, objectively measuring current substance use with a point-of-interview breathalyser and urinalysis, and examining changes in healthcare utilisation using data obtained from a healthcare information exchange. We are collecting interpersonal data using in-depth individual interviews with residents and staff. We are collecting organisational data using field observation and a cost-effectiveness study, and we are collecting community data using neighbourhood mapping.
The UTHealth institutional review board approved all protocols. We will disseminate study findings via conference presentations, peer-reviewed publications and brief community reports.
随着美国继续与阿片类药物泛滥作斗争，康复住所仍然是康复者的宝贵服务。虽然越来越多的文献描述了居住在康复住所的人所经历的积极结果，但对于那些在康复过程中服用阿片类药物使用障碍（MOUD）药物的人在这些住所中的体验却知之甚少。因此，本研究有三个目的：（1）扩大符合国家康复住所联盟标准的康复住所的供应，为正在康复过程中服用 MOUD 的个人提供服务；（2）评估康复住所对正在康复过程中服用 MOUD 的人的效果；（3）比较康复住所与常规治疗的成本效益。
我们与社区合作伙伴合作，在德克萨斯州开设了 15 家康复住所，为正在康复过程中服用 MOUD 的人提供住所。我们正在收集定量和定性数据，以评估个人、人际关系、组织和社区层面的结果。在个人层面，我们使用纵向调查评估行为和心理社会结构的变化，使用即时呼吸测试和尿液分析客观测量当前的物质使用情况，并使用从医疗保健信息交换中获得的数据检查医疗保健利用的变化。我们通过对居民和工作人员进行深入的个人访谈收集人际关系数据。我们使用现场观察和成本效益研究收集组织数据，使用社区地图收集社区数据。
UTHealth 机构审查委员会批准了所有协议。我们将通过会议演讲、同行评议出版物和简短的社区报告来传播研究结果。
